C-QIYPCalico
aging biology, systems biology, drug development
discoverydiscoveringsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-QIYP
C-QIYPC-QIYPaging biology, systems biology, drug development
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Calico aging biology, systems biology, drug development
Calico works to understand the biology that controls aging and lifespan. The company uses basic aging biology, state-of-the-art technology, advanced computing, collaborations, and drug development to discover and develop interventions for diseases associated with aging. Its progress is described through publications, collaborations, and an expanding pipeline of early- and clinical-stage compounds.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Calico — Translational · Bottom quartile. Derived deterministically from 26 extracted project(s). Most-advanced status: phase 2. Band: translational. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic